No Data
No Data
Stifel Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $49
This Expand Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Oruka Therapeutics Initiated at Outperform by Wolfe Research
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Wolfe Research Initiates Oruka Therapeutics(ORKA.US) With Buy Rating, Announces Target Price $20
Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session